Acute Sinusitis Market size was over USD 2.24 billion in 2023 and is anticipated to reach USD 5.6 billion by 2036, growing at around 7.3% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of acute sinusitis is estimated at USD 2.37 billion.
The growth of the market can be attributed to the increasing cases of acute sinusitis backed by unhealthy lifestyle, and habits, such as, smoking. Around 25-40 out of every 1000 individual suffer from acute sinusitis, every year, globally. It is more common in adults that children. Chronic sinusitis affects 12-15% of the population. Acute sinus can be caused by bacterial, viral, or fungal infections, or due to the presence of polyps and nasal tumors. It causes extreme discomfort, headache, breathing issues, cough, and nasal congestion, which increases the demand for effective treatment to provide immediate relief as well as long term cure. The increasing demand for better treatment solutions for acute sinusitis is estimated to boost the market growth.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
7.3% |
|
Base Year Market Size (2023) |
USD 2.24 billion |
|
Forecast Year Market Size (2036) |
USD 5.6 billion |
|
Regional Scope |
|
The global acute sinusitis market is segmented by diagnosis into nasal endoscopy, imaging test, and others, out of which, the imaging test segment is anticipated to hold a notable share in the market during the forecast period on account of high accuracy of imaging test, such as, CT scan, and MRI. The acute sinusitis market is segmented by treatment into saline nasal spray, corticosteroid spray, oral decongestant therapy, sinus dilation devices, medications, and surgery. Out of these, the saline nasal spray segment is anticipated to garner a significant share during the forecast period owing to their easy availability at drug stores, and affordable prices. On the other hand, the medication segment is also estimated to gain significant share, on the back of its effectiveness in relieving acute sinus in a short time.
|
By Diagnosis |
|
|
By Treatment |
|
|
By End-User
|
|
North America Market Statistics
Regionally, the global acute sinusitis market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America is predicted to hold largest revenue share by 2036, on the back of high prevalence of sinusitis in the region. Over 28 million adults were diagnosed with sinusitis in the United States, in 2020. Moreover, the increasing government investment in healthcare sector and favorable medical reimbursement policies are estimated to boost the regional market growth. According to the World Health Organization (WHO), as of 2018, 16.416 % of the GDP was spent on the healthcare sector in North America.
APAC Market Analysis
The acute sinusitis market in the Asia Pacific is estimated to witness notable growth over the forecast period accounting to the increasing cases of respiratory diseases, due to the increasing pollution in major cities, such as, Shanghai, Hotan, Delhi, Kathmandu, and Kabul, among others. Moreover, increasing investment in public healthcare system is estimated to boost the market growth in the region.
· August 6, 2020: Novartis AG announced the approval of Xolair as an add-on therapy with intranasal corticosteroids for the treatment of rhinosinusitis with nasal polyps.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?